Epstein Secrets

er Bond Income Other Income Div/Int Chgd Loan Interest Chgd Repurchse Int Chgd Rev Repur Int Income Net Total Cash Income The understanding of Credit Suisse First Boston is that credit balances held in your account are pending reinvestment. YTD Opening Balance Purchases Sales Funds Received Funds Withdrawn Net

36FY0 FROM 746FY0 S/D FINANCING RETURN FROM 746FY0 TO 2F8EE0 S/D FINANCING FROM 2F8EE0 TO 746FY0 FUNDS RECEIVED BY WIRE -2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 9,740 AMGEN OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 2,000,000 AMGEN INC NT Z

er Bond Income Other Income Div/Int Chgd Loan Interest Chgd Repurchse Int Chgd Rev Repur Int Income Net Total Cash Income The understanding of Credit Suisse First Boston is that credit balances held in your account are pending reinvestment YTD 268.53 100.00 Opening Balance Purchases Sales Funds Received Funds

ld PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 11/06/2022 AMERICAN FINL GROUP INC OHIO SR 01.4861 06/02/2033 NT CV1. AMGEN INC NT ZER CV 32 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC EFTA01593609 03/01/2032 SR 02.5000 04/15/2011 03.7500 08/01/

er Bond Income Other Income Div/Int Chgd Loan Interest Chgd Repurchse Int Chgd Rev Repur Int Income Net Total Cash Income The understanding of Credit Suisse First Boston is that credit balances held in your account are pending reinvestment YTD 268.53 100.00 Opening Balance Purchases Sales Funds Received Funds

0 2,000,000 125,000 1,075,000 :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 AMGEN INC NT ZER CV 32 11/06/2022 03/01/2032 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC SR 02.5000 04/15/2011 EFTA01593661 03